No evidence of microsatellite instability but frequent loss of heterozygosity in primary resected lung cancer

Environmental and Molecular Mutagenesis

Volumn 30, Issue 2, 1997, Pages 217-223

  Pylkkänen, Lea ^a   Karjalainen, Antti ^a   Anttila, Sisko ^a   Vainio, Harri ^a,b   Husgafvel Pursiainen, Kirsti ^a  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Genetic alterations; Human lung cancer; Loss of heterozygosity; Microsatellite instability

Indexed keywords

MICROSATELLITE DNA;

ADULT; AGED; ARTICLE; FEMALE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CHROMOSOMES, HUMAN; DNA, NEOPLASM; FEMALE; GENETIC MARKERS; HETEROZYGOTE; HUMANS; LUNG NEOPLASMS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; SMOKING;

EID: 1842371454     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2280(1997)30:2<217::AID-EM14>3.0.CO;2-G     Document Type: Article

References (60)

1. Aaltonen LA, Peltomäki P, Leach FS, Sistonen P, Pylkkänen L, Mecklin J-P, Järvinen H, Powell SM, Jen J, Hamilton SR, Petersen GM, Kinzler KW, Vogelstein B, de la Chapelle A (1993): Clues to pathogenesis of familial colorectal cancer. Science 260:810-816.
2. Braun MM, Caporaso NE, Page WF, Hoover RN (1994): Genetic component of lung cancer: Cohort study of twins. Lancet 334:440-443.
3. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, Kane M, Earabino C, Lipford J, Lindblom A, Tannergard P, Bollag RJ, Godwin AR, Ward DC, Nordenskjöld M, Fishel R, Kolodner R, Kiskay RM (1994): Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368:258-261.
4. Cairns P, Tokino K, Eby Y, Sidransky D (1994): Homozygous deletions of 9p21 in primary human bladder tumours detected by comparative multiplex polymerase chain reaction. Cancer Res 54:1422-1424.
5. Canzian F, Ushijima T, Serikawa T, Wakabayashi K, Sugimura T, Nagao M (1994): Instability of microsatellite in rat colon tumors induced by heterocyclic amines. Cancer Res 54:6315-6317.
6. Devereux TR (1996): Molecular mechanisms of lung cancer. Interaction of environmental and genetic factors. Chest 109:14s-19s.
7. Fishel R, Lescoe MK, Rao MRS, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R (1993): The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75:1027-1038.
8. Fong KM, Zimmerman PV, Smith PJ (1995): Microsatellite instability and other molecular abnormalities in non-small-cell lung cancer. Cancer Res 55:28-30.
9. Greenblatt MS, Harris CC (1995): Molecular genetics of lung cancer. Cancer Surveys 25:293-313.
10. INK4B is a potential effector of TGF-b(β) induced cell cycle arrest. Nature 371:257-261.
11. Hayashi N, Sugimoto Y, Tsuchiya E, Ogava M, Nakamura Y (1994): Somatic mutations of the MTS (multiple tumor suppressor) 1/CDK41 (cyclin-dependent kinase-4 inhibitor) gene in human primary non-small-cell lung carcinomas. Biochem Biophys Res Commun 202:1426-1430.
12. Hibi K, Takahashi T, Yamakawa K, Ueda R, Sekido Y, Ariyoshi Y, Suyama M, Takagi H, Nakamura Y, Takahashi T (1992): Three distinct regions involved in 3p deletion in human lung cancer. Oncogene 7:445-449.
13. Horio Y, Takahashi T, Kuroishi T, Hibi K, Suyama M, Niimi T, Shimokata K, Yamakawa K, Nakamura Y, Ueda R, Takahashi T (1993): Prognostic significance of p53 mutations and 3p deletions in primary resected non-small-cell lung cancer. Cancer Res 53:1-4.
14. IARC (1987): "Monographs on the Evaluation of Carcinogenic Risks to Humans. Overall Evaluations of Carcinogenicity: An updating of IARC monograph volumes 1 to 42, suppl. 7." Lyon: International Agency for Research on Cancer.
15. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M (1993): Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363:558-561.
16. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS III, Johnson BE, Skolnick MH (1994): A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440.
17. Katabuchi H, van Rees B, Lambers AR, Ronnett BM, Blazes MS, Leach FS, Cho KR, Hedrick L (1995): Mutations in DNA mismatch repair genes are not responsible for microsatellite instability in most sporadic endometrial carcinomas. Cancer Res 55:5556-5560.
18. Kok K, Osinga J, Carrit B, Davis MB, van der Hout AH, van der Veen AY, Landsvater RM, de Leij LFMH, Berendsen HH, Postmus PE, Poppema S, Buys CHCM (1987): Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer. Nature 330:578-581.
19. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, Peltomäki P, Sistonen P, Aaltonen LA, Nyström-Lahti M, Muan X-Y, Fournier REK, Todd S, Lewis T, Leach RJ, Naylor SL, Weissenbach J, Mecklin J-P, Järvinen H, Petersen GM, Hamilton SR, Green J, Jass J, Watson P, Lynch HT, Trent JM, de la Chapelle A, Kinzler KW, Vogelstein B (1993): Mutations of a MutS homolog in hereditary non-polyposis colorectal cancer. Cell 75:1215-1225.
20. Lukeis R, Irving L, Garson M, Hasthorpe S (1990): Cytogenetics of non-small-cell lung cancer: Analysis of consistent non-random abnormalities. Genes Chromosomes Cancer 2:116-124.
21. MacPhee DG (1995): Mismatch repair, somatic mutations, and the origin of cancer. Cancer Res 55:5489-5492.
22. Mao L, Lee DJ, Tockman MS, Erozan YS, Askin F, Sidransky D (1994): Microsatellite alterations as clonal markers for the detection of human cancer. Proc Natl Acad Sci USA 91:9871-9875.
23. Merlo A, Gabrielson E, Askin F, Sidransky D (1994a): Frequent loss of chromosome 9 in human non-small-cell lung cancer. Cancer Res 54:640-642.
24. Merlo A, Mabry M, Gabrielson E, Vollmer R, Baylin SB, Sidransky D (1994b): Frequent microsatellite instability in primary small-cell lung cancer. Cancer Res 54:2098-2101.
25. Mitsudomi T, Oyama T, Nishida K, Ogami A, Osaki T, Sugio K, Yasumoto K, Sugimachi K, Gazdar AF (1996): Loss of heterozygosity at 3p in non-small-cell lung cancer and its prognostic implication. Clin Cancer Res 2:1185-1189.
26. Nakagawa K, Conrad NK, Williams JP, Johnson BE, Kelley MJ (1995): Mechanism of inactivation of CDKN2 and MTS2 in non-small-cell lung cancer and association with advanced stage. Oncogene 11:1843-1851.
27. Nicolaides NC, Papadopoulos N, Liu B, Wei Y-F, Carter KC, Ruben SM, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CA, Adams MD, Venter JC, Dunlop MG, Hamilton SR, Petersen GM, de la Chapelle A, Vogelstein B, Kinzler KW (1994): Mutation of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 371:75-80.
28. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA (1994): Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368:753-756.
29. Ohta M, Inoue H, Cotticelli HG, Kastury K, Baffa R, Palzzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM, Huebner K (1996): The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84:587-597.
30. Okamoto A, Hussain SP, Hagiwara K, Spillare EA, Rusin MR, Demetrick DJ, Serrano M, Hannon GJ, Shiseki M, Zariwala M, Xiong Y, Beach DH, Yokota J, Harris CC (1995): Mutations in the p16 ink4/MTS1/CDKN2, p15ink4B/MTS2 and p18 genes in primary and metastatic lung cancer. Cancer Res 55:1448-1451.
31. Olopade OI, Buchhagen DL, Malik K, Sherman J, Nobori T, Bader S, Nau MM, Gazdar AF, Minna JD, Diaz MO (1993): Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers. Cancer Res 53:2410-2415.
32. Packenham JP, Taylor JA, White C, Anna CH, Barrett JC, Devereux TR (1995): Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small-cell lung cancers. Clin Cancer Res 1:687-690.
33. Papadopoulos N, Nicolaides NC, Wei Y-F, Rube SM, Carter KC, Rosen CA, Haseltine WA, Fleishmann RD, Fraser CM, Adams MD, Venter JC, Hamilton SR, Petersen GM, Watson P, Lynch HT, Peltomäki P, Mecklin J-P, de la Chapelle A, Kinzler KW, Vogelstein B (1994): Mutation of a mutL homolog in hereditary colon cancer. Science 263:1625-1629.
34. Parsons R, Li G-M, Longley MJ (1993): Hypermutability and mismatch repair deficiency in RER+ tumour cells. Cell 75:1215-1225.
35. Peltomäki P, Lothe RA, Aaltonen LA, Pylkkänen L, Nyström-Lahti M, Seruca R, David L, Holm R, Ryberg D, Haugen A, Brogger A, Børresen A-L, de la Chapelle A (1993): Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res 53:5853-5855.
36. Radford DM, Fair KL, Phillips NJ, Ritter JH, Steinbrueck T, Holt MS, Donis-Keller H (1995): Allelotyping of ductal carcinoma in situ of the breast: Deletion of loci 8p, 13q, 16q, 17p, and 17q. Cancer Res 55:3399-3405.
37. Rasio D, Negrini M, Manenti G, Dragani TA, Croce CM (1995): Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: Identification of three independent regions. Cancer Res 55:3988-3991.
38. Ridanpää M, Karjalainen A, Anttila S, Vainio H, Husgafvel-Pursiainen K (1994): Genetic alterations in p53 and k-ras in lung cancer in relation to histopathology of the tumor and smoking of the patient. Int J Oncol 5: 1109-1117.
39. Ryberg D, Lindstedt BA, Zienolddiny S, Haugen A (1995): A hereditary genetic marker closely associated with microsatellite instability in lung cancer. Cancer Res 55:3996-3999.
40. Sato S, Nakamura Y, Tsuchiay E (1994): Difference in allelotype between squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res 54:5652-5655.
41. Sellers TA, Bailey-Wilson JE, Elston RC, Wilson AF, Elston GZ, Ooi WL, Rothschild H (1990): Evidence for Mendelian inheritance in the pathogenesis of lung cancer. J Natl Cancer Inst 82:1272-1279.
42. Sellers TA, Potter JD, Bailey-Wilson JE, Rich SS, Rothschild H, Elston RC (1992): Lung cancer detection and prevention: Evidence for an interaction between smoking and genetic predisposition. Cancer Res 52:2694-2697.
43. Serrano M, Hannon GJ, Beach D (1993): A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704-707.
44. Shimizu T, Sekiya T (1995): Loss of heterozygosity at 9p21 loci and mutations of the MTS1 and MTS2 genes in human lung cancers. Int J Cancer 63:616-620.
45. Shridhar V, Siegfried J, Hunt J, del Mar Alonso M, Smith DI (1994): Genetic instability of microsatellite sequences in many non-small-cell lung carcinomas. Cancer Res 54:2084-2087.
46. Sozzi G, Veronese ML, Negrini M, Baffa R, Cotticelli MG, Inoue H, Tornielli S, Pilotti S, De Gregorio L, Pastorino U, Pierotti MA, Ohta M, Huebner K, Croce CM (1996): The FHIT gene at 13p14.2 is abnormal in lung cancer. Cell 85:17-26.
47. Speicher MR (1995): Microsatellite instability in human cancer. Oncology Res 7:267-275.
48. Stanbridge E (1992): Functional evidence for human tumour suppressor genes: Chromosome and molecular genetic studies. Cancer Surveys 12:5-24.
49. Thiberville L, Bourguignon J, Metayer J, Bost F, Diarra-Mehrpour M, Bignon J, Lam S, Martin J-P, Nouvel G (1995): Frequency and prognostic evaluation of 3p21-22 allelic losses in non-small-cell lung cancer. Int J Cancer 64:371-377.
50. Thibodeau SN, Bren G, Schaid P (1993): Microsatellite instability in cancer of the proximal colon. Science 260:812-816.
51. Tsuchiya E, Nakamura Y, Weng SY, Nakagawa K, Tsuchiya S, Sugano H, Kitagawa T (1992): Allelotype of non-small-cell lung carcinoma - comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Cancer Res 52:2478-2481.
52. de Vos S, Miller CW, Takeuchi S, Gombart AF, Cho SK, Koeffler HP (1995): Alterations of CDKN2 (p16) in non-small-cell lung cancer. Genes Chromosomes Cancer 14:164-170.
53. Washimi O, Nagatake M, Osada H, Ueda R, Koshikawa T, Seki T, Takahshi T, Takahashsi T (1995): In vivo occurrence of p16 (MTS1) and p15 (MTS2) alterations preferentially in non-small-cell lung cancers. Cancer Res 55:514-517.
54. Weissenbach J, Gyapa G, Dib C, Vignal A, Morissette J, Millasseau P, Vaysseix G, Lathrop M (1992): A second-generation linkage map of the human genome. Nature 359:794-801.
55. Weston A, Willey JC, Modali R, Sugimura H, McDowell EM, Resau J, Light B, Haugen A, Mann DL, Trump B, Harris C (1989): Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung. Proc Natl Acad Sci USA 86:5099-5103.
56. Whang-Peng J, Kao-Shan CS, Lee EC, Bunn PA, Carney DN, Gazdar AF, Minna JD (1982): Specific chromosomal defect associated with human small-cell lung cancer: Deletion 3p(14-23). Science 215:181-182.
57. WHO (1996): "The tobacco epidemic: A global public health emergency. Fact sheet no. 118." Geneva: World Health Organization Press Office.
58. Xiao S, Li D, Corson JM, Vijg J, Fletcher JA (1995): Codeletion of p15 and p16 genes in primary non-small-cell lung carcinoma. Cancer Res 55:2968-2971.
59. Yokota J, Wada M, Shimosato Y, Terada M, Sugimura T (1987): Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. Proc Natl Acad Sci USA 84:9252-9256.
60. Yokoyama S, Yamakawa K, Tsuchiya E, Murata M, Sakiyama S, Nakamura Y (1992): Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res 52:873-877.